Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million
14/11/2024 06:32
Nov 14 (Reuters) - PharmaSGP Holding 9M adjusted EBITDA margin 30.5%. * 9M revenue EUR 88.6 million * 9M EBITDA EUR 26.9 million * 9M EBITDA margin 30.4% * outlook FY revenue EUR 112-117 million * outlook FY adjusted EBITDA EUR 35-38 million
Recent news on PharmaSGP Holding SE
See all newsBrief: PharmaSGP Holding Outlook FY Revenue EUR 132-138 Million
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million